BiotechTube

agalsidase beta

ApprovedTerminated
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Fabry Disease

Conditions

Fabry Disease, Alpha Galactosidase A Deficiency

Trial Timeline

May 28, 2006 → Feb 9, 2024

NCT ID
NCT00230607

About agalsidase beta

agalsidase beta is a approved stage product being developed by Sanofi for Fabry Disease. The current trial status is terminated. This product is registered under clinical trial identifier NCT00230607. Target conditions include Fabry Disease, Alpha Galactosidase A Deficiency.

What happened to similar drugs?

8 of 20 similar drugs in Fabry Disease were approved

Approved (8) Terminated (3) Active (11)
✅Fabrazyme (agalsidase beta)SanofiApproved
✅agalsidase betaSanofiApproved
✅AGALSIDASE BETA (GZ419828) + Acetaminophen + Diphenhydramine + Dexamethasone + Montelukast + Loratadine + Cetirizine + FexofenadineSanofiApproved
✅Agalsidase betaSanofiApproved
✅agalsidase beta (GZ419828) + agalsidase alfaSanofiApproved
✅Agalsidase betaSanofiApproved
✅Fabrazyme (agalsidase beta) + PlaceboSanofiApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (5)

NCT IDPhaseStatus
NCT05054387ApprovedCompleted
NCT01650779ApprovedCompleted
NCT00230607ApprovedTerminated
NCT00140621ApprovedCompleted
NCT00081497ApprovedCompleted

Competing Products

20 competing products in Fabry Disease

See all competitors
ProductCompanyStageHype Score
LucerastatIdorsiaPhase 3
38
Fabrazyme (agalsidase beta)SanofiPhase 2
35
Venglustat (GZ402671) + PlaceboSanofiPhase 3
44
Fabrazyme (agalsidase beta) + Fabrazyme (agalsidase beta)SanofiPhase 2
27
TropicamideSanofiPre-clinical
26
Fabrazyme (agalsidase beta)SanofiApproved
35
agalsidase betaSanofiApproved
43
AGALSIDASE BETA (GZ419828) + Acetaminophen + Diphenhydramine + Dexamethasone + Montelukast + Loratadine + Cetirizine + FexofenadineSanofiApproved
43
Gabapentin + placeboSanofiPhase 2
27
Agalsidase betaSanofiApproved
43
GZ/SAR402671SanofiPhase 2
35
agalsidase beta (GZ419828) + agalsidase alfaSanofiApproved
35
Fabrazyme (agalsidase beta)SanofiPhase 3
40
Venglustat (GZ402671) + Agalsidase alfa + Agalsidase beta (GZ419828) + MigalastatSanofiPhase 3
44
IohexolSanofiPhase 1
21
GZ/SAR402671SanofiPhase 2
35
Fabrazyme (agalsidase beta)SanofiPhase 2
35
Agalsidase betaSanofiApproved
43
Fabrazyme (agalsidase beta) + PlaceboSanofiApproved
43
Agalsidase beta + Agalsidase betaSanofiPhase 3
40